COX-2-IN-60
COX-2-IN-60 is a potent, orally active, and selective COX-2 inhibitor with an IC50 of 0.06 μM. COX-2-IN-60 exhibits ~100-fold selectivity over COX-1 (IC50 = 5.93 ). COX-2-IN-60 reduces oxidative stress and neuroinflammatory cytokines, and effectively counteracts epileptogenesis. COX-2-IN-60 exhibits significant anticonvulsant effects and protects against hippocampal injury by suppressing oxidative stress (reducing MDA and NO), pro-inflammatory signaling (reducing TNF-α and IL-6), and glial activationin in the Pilocarpine (HY-B0726A)-induced seizure mouse model. COX-2-IN-60 can be used for the research on neuroinflammatory and epilepsy.
For research use only. We do not sell to patients.
- CAS No.: 3073624-74-2
- Formula: C17H15BrN2O4
- Molecular Weight:391.22
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
|
COX-2 0.06 μM (IC50) |
COX-1 5.93 μM (IC50) |
COX-2-IN-60 (compound 7b) not only forms key hydrogen bonds with Thr29, Val289, and Arg119 like Valproic acid (HY-10585), but also establishes additional bonds via its phenoxy group with Thr333 and its hydrazone carbonyl with Tyr193, thereby achieving superior binding stability[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
COX-2-IN-60 suppresses seizure and achieves complete protection with no observed mortality in the Pentylenetetrazol (PTZ)-induced acute seizure mouse model[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Pilocarpine (HY-B0726A)-induced seizure model[1]
-
Dosage:20 mg/kg
-
Administration:p.o., 30 min pre-Pilocarpine
-
Result:Produced significant anticonvulsant effect. Prolonged the latency to stage 3 seizures by 188.6%. Significantly attenuated seizure progression. Significantly reduced MDA and nitrite levels by 67.15% and 41.01%, respectively. Significantly reduced cytokines by 56.95% (TNF-a) and 62.97% (IL-6). effectively mitigated excitotoxicity, as indicated by a 61.5% reduction in hippocampal glutamate levels. Downregulated glial fibrillary acidic protein (GFAP), and ionized calcium-binding adapter molecule 1 (Iba-1) by 73.91% and 49.79%, respectively.
Chemical Information
-
CAS No. 3073624-74-2
-
Molecular Weight 391.22
-
Formula C17H15BrN2O4
-
SMILES
O=C(O)COC1=CC=C(Br)C=C1/C=N/NC(CC2=CC=CC=C2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
COX-2-IN-60 Related Classifications
HY-179142 Related Classifications
Powered by Bioz